Apelin, the related peptide ligand apela/elabela, and their common receptor APJ/Aplnr regulate cardiovascular morphogenesis during development, but there is increasing evidence linking these molecules to cancer and other pathobiological processes including inflammation-related diseases14–16. The gene discussed is APLNR; the disease is cancer.